SFI — Sopharma Properties ADSITS Balance Sheet
0.000.00%
- €85.61m
- €82.66m
- €9.56m
Annual balance sheet for Sopharma Properties ADSITS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.84 | 1.06 | 1.04 | 0.381 | 0.419 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.161 | 0.152 | 0.177 | 0.176 | 0.133 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.02 | 1.28 | 1.3 | 3.21 | 1.61 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.009 | 0.006 | 0.014 | 0.014 | 0.011 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 45.4 | 47.2 | 49.4 | 54.3 | 55 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.36 | 5.34 | 3.06 | 4.51 | 2.66 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.76 | 6.17 | 4 | 5.38 | 3.45 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 37.6 | 41.1 | 45.4 | 48.9 | 51.5 |
| Total Liabilities & Shareholders' Equity | 45.4 | 47.2 | 49.4 | 54.3 | 55 |
| Total Common Shares Outstanding |